Pathology Doctors in Guam Medicare Details, Address, Contact
4 Pathology doctors found. Showing 1 - 4
 Dr. Todd Lilje, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Medicare Enrolled Practice Location: U.s. Naval Hospital Guam, Building #50 Farenholt Ave., Agana Heights, GU 96910 Phone: 671-344-9378 |
Dr. Mohamad H Alsabban, M.D. Pathology - Cytopathology Medicare: Accepting Medicare Assignments Practice Location: 133 Route 3, Dededo, GU 96929 Phone: 671-645-5500 |
Dr. Arthur J Loerzel, MD FCAP Pathology - Anatomic Pathology Medicare: Not Enrolled in Medicare Practice Location: 850 Governor Carlos Camacho Road, Oka Tamuning, GU 96913 Phone: 671-647-2418 Fax: 671-649-5508 |
Dr. Jeffrey Scott Nine, M.D. Pathology - Forensic Pathology Medicare: Not Enrolled in Medicare Practice Location: Guam Office Of The Chief Medical Examiner, 325 Duenas Drive, Tamuning, GU 96913 Phone: 671-646-9363 Fax: 671-646-8860 |
News Archive
International study investigates the genetic cause of stuttering
Researchers need 3,000 Australian stutterers for an international study that is searching for the genes in human DNA which cause stuttering.
Integrative oncology program aims to address cancer patients' needs from every angle
The very instant Penny Kukovec was diagnosed with breast cancer her world permanently changed. Suddenly, it felt as if her life was out of her control. She felt powerless and overwhelmed. There were so many unanswered questions.
Unanticipated consequences of healthcare information technology
Researchers at the University of Pennsylvania School of Medicine and the Agency for Healthcare Research and Quality (AHRQ) have developed a framework to help hospital managers, physicians, and nurses handle the tough challenges of implementing health information technology (HIT) by directly addressing the unintended consequences that undermine safety and quality.
Sosei Group assigns its SD281 drug discovery programme to Biocopea
Sosei Group Corporation, a biopharmaceutical company, today announces the assignment of the drug discovery programme, SD281 and its analogues, to Biocopea Limited, a UK biotechnology company and subsidiary of PepTcell Limited. These compounds, based on a metabolite of a well-known drug, were shown by Sosei to have pronounced anti-inflammatory properties.
Kinase inhibitors could provide an effective way to treat high-risk leukaemia
Australian scientists have found what could prove to be a new and effective way to treat a particularly aggressive blood cancer in children.
› Verified 9 days ago